BioDelivery Sciences International Company Profile (NASDAQ:BDSI)

About BioDelivery Sciences International

BioDelivery Sciences International logoBioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: BDSI
  • CUSIP: 09060J10
Key Metrics:
  • Previous Close: $2.83
  • 50 Day Moving Average: $2.59
  • 200 Day Moving Average: $2.67
  • 52-Week Range: $1.86 - $7.04
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.45
  • P/E Growth: -0.10
  • Market Cap: $157.70M
  • Outstanding Shares: 53,639,000
  • Beta: 2.2
Profitability:
  • Net Margins: -109.64%
  • Return on Equity: -233.80%
  • Return on Assets: -53.02%
Debt:
  • Debt-to-Equity Ratio: 3.24%
  • Current Ratio: 2.37%
  • Quick Ratio: 2.21%
Additional Links:
Companies Related to BioDelivery Sciences International:

Analyst Ratings

Consensus Ratings for BioDelivery Sciences International (NASDAQ:BDSI) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.67 (160.77% upside)

Analysts' Ratings History for BioDelivery Sciences International (NASDAQ:BDSI)
Show:
DateFirmActionRatingPrice TargetDetails
9/23/2016Janney Montgomery ScottUpgradeNeutral -> Buy$2.45 -> $4.00View Rating Details
9/20/2016FBR & CoReiterated RatingBuyView Rating Details
8/10/2016Cantor FitzgeraldReiterated RatingHoldView Rating Details
8/10/2016Piper Jaffray Cos.Reiterated RatingSell$4.00View Rating Details
3/28/2016Roth CapitalReiterated RatingBuyView Rating Details
3/14/2016LaidlawLower Price TargetBuy$17.00 -> $11.00View Rating Details
9/18/2015William BlairReiterated RatingBuy$17.00View Rating Details
12/30/2014Summer StreetSet Price TargetBuy$28.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for BioDelivery Sciences International (NASDAQ:BDSI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.31)($0.31)$3.35 million$5.00 millionViewN/AView Earnings Details
5/10/2016Q116($0.35)($0.36)$2.96 million$3.00 millionViewListenView Earnings Details
3/10/2016Q415$0.55$0.19$52.40 million$32.20 millionViewListenView Earnings Details
11/9/2015Q315($0.34)($0.39)$1.56 million$1.20 millionViewN/AView Earnings Details
8/10/2015Q215($0.31)($0.37)$3.29 million$1.70 millionViewListenView Earnings Details
5/11/2015Q115($0.20)($0.16)$10.80 million$13.10 millionViewListenView Earnings Details
3/16/2015Q414($0.33)($0.51)$4.00 million$2.50 millionViewN/AView Earnings Details
11/11/2014($0.29)($0.39)ViewN/AView Earnings Details
8/15/2014($0.07)($0.14)ViewN/AView Earnings Details
5/9/2014Q114($0.15)($0.11)$11.60 million$20.69 millionViewN/AView Earnings Details
3/14/2014($0.22)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioDelivery Sciences International (NASDAQ:BDSI)
Current Year EPS Consensus Estimate: $-1.15 EPS
Next Year EPS Consensus Estimate: $-0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.40)($0.36)($0.38)
Q2 20162($0.34)($0.34)($0.34)
Q3 20163($0.28)($0.25)($0.26)
Q4 20163($0.26)($0.23)($0.25)
Q1 20171($0.20)($0.20)($0.20)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioDelivery Sciences International (NASDAQ:BDSI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioDelivery Sciences International (NASDAQ:BDSI)
Insider Ownership Percentage: 9.00%
Institutional Ownership Percentage: 60.12%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2016Francis E Odonnell JrDirectorSell100,000$2.57$257,000.00View SEC Filing  
9/23/2016Niraj VasishtInsiderSell47,000$2.43$114,210.00View SEC Filing  
9/22/2016Paolantonio Ernest Robert DeCFOSell14,800$2.44$36,112.00View SEC Filing  
8/25/2016Barry I FeinbergDirectorBuy2,500$2.55$6,375.00View SEC Filing  
8/11/2016William B StoneDirectorSell16,000$2.57$41,120.00View SEC Filing  
3/21/2016Charles BramlageDirectorBuy8,850$2.82$24,957.00View SEC Filing  
3/18/2016Barry I FeinbergDirectorBuy10,000$2.74$27,400.00View SEC Filing  
3/18/2016Niraj VasishtCTOBuy1,000$2.80$2,800.00View SEC Filing  
3/17/2016Paolantonio Ernest Robert DeCFOBuy4,000$2.60$10,400.00View SEC Filing  
11/24/2015Francis E Odonnell JrDirectorSell50,000$6.01$300,500.00View SEC Filing  
11/13/2015Thomas D'alonzoDirectorBuy4,528$5.52$24,994.56View SEC Filing  
9/3/2015Francis E Odonnell JrDirectorSell20,000$6.43$128,600.00View SEC Filing  
8/26/2015Paolantonio Ernest Robert DeCFOBuy1,650$6.20$10,230.00View SEC Filing  
8/13/2015William B StoneDirectorSell11,500$7.01$80,615.00View SEC Filing  
6/16/2015Francis E Odonnell JrDirectorSell21,597$8.03$173,423.91View SEC Filing  
6/16/2015Mark A SirgoCEOSell4,187$7.97$33,370.39View SEC Filing  
5/26/2015Barry I FeinbergDirectorBuy2,000$7.84$15,680.00View SEC Filing  
5/14/2015Barry I FeinbergDirectorBuy2,000$8.54$17,080.00View SEC Filing  
5/13/2015Thomas D'alonzoDirectorBuy6,226$8.07$50,243.82View SEC Filing  
12/26/2014Francis E Odonnell JrDirectorSell70,000$12.00$840,000.00View SEC Filing  
12/15/2014Mark A SirgoCEOBuy2,500$12.23$30,575.00View SEC Filing  
12/10/2014Samuel P Sears JrDirectorSell7,853$15.03$118,030.59View SEC Filing  
11/12/2014William B StoneDirectorSell14,000$16.11$225,540.00View SEC Filing  
9/4/2014Barry I FeinbergDirectorBuy1,000$15.18$15,180.00View SEC Filing  
9/4/2014Mark A SirgoCEOBuy2,000$15.04$30,080.00View SEC Filing  
8/27/2014Andrew L FinnEVPSell90,000$15.00$1,350,000.00View SEC Filing  
8/22/2014Charles BramlageDirectorBuy1,800$13.85$24,930.00View SEC Filing  
6/25/2014Paolantonio Ernest Robert DeCFOBuy1,250$12.13$15,162.50View SEC Filing  
6/12/2014Samuel P Sears JrDirectorSell5,000$12.33$61,650.00View SEC Filing  
6/11/2014Francis E Odonnell JrDirectorSell125,000$11.04$1,380,000.00View SEC Filing  
3/26/2014Francis Odonnell, Jr.DirectorSell50,000$8.04$402,000.00View SEC Filing  
3/20/2014Samuel Sears, Jr.DirectorSell4,000$9.00$36,000.00View SEC Filing  
3/11/2014Andrew FinnEVPSell80,000$9.99$799,200.00View SEC Filing  
3/11/2014William StoneDirectorSell35,000$10.00$350,000.00View SEC Filing  
2/20/2014Andrew FinnEVPSell18,737$8.84$165,635.08View SEC Filing  
2/20/2014Francis Odonnell, Jr.DirectorSell70,000$8.92$624,400.00View SEC Filing  
2/20/2014Mark SirgoCEOSell42,000$8.92$374,640.00View SEC Filing  
1/24/2014Andrew FinnEVPSell143,679$9.03$1,297,421.37View SEC Filing  
1/24/2014James McnultySVPSell89,223$8.73$778,916.79View SEC Filing  
1/24/2014John SheaDirectorSell130,000$8.78$1,141,400.00View SEC Filing  
1/24/2014Mark SirgoCEOSell116,253$9.01$1,047,439.53View SEC Filing  
11/18/2013Mark SirgoCEOBuy2,337$4.29$10,025.73View SEC Filing  
9/19/2013Francis Odonnell, Jr.DirectorSell95,000$5.36$509,200.00View SEC Filing  
9/11/2013Samuel P Sears JrDirectorSell2,000$5.37$10,740.00View SEC Filing  
9/9/2013Samuel P Sears JrDirectorSell7,500$5.05$37,875.00View SEC Filing  
8/26/2013Andrew FinnEVPBuy5,000$4.58$22,900.00View SEC Filing  
8/16/2013Mark SirgoCEOBuy5,100$4.43$22,593.00View SEC Filing  
8/15/2013William StoneDirectorSell6,825$4.44$30,303.00View SEC Filing  
8/14/2013James McnultyCFOBuy5,000$4.50$22,500.00View SEC Filing  
6/21/2013Mark A SirgoCEOBuy3,400$4.30$14,620.00View SEC Filing  
6/20/2013Francis E Odonnell JrDirectorSell72,689$4.36$316,924.04View SEC Filing  
6/5/2013Samuel P Sears JrDirectorSell5,000$4.42$22,100.00View SEC Filing  
12/21/2012Andrew L FinnEVPBuy3,000$3.85$11,550.00View SEC Filing  
12/21/2012Mark A SirgoCEOBuy4,975$4.02$19,999.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioDelivery Sciences International (NASDAQ:BDSI)
DateHeadline
News IconInterested Penny Stock Investors Keen on Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 28 at 3:51 PM
News IconActive biotech company shares in the news: Anavex Life Sciences Corp. (NASDAQ:AVXL), BioDelivery Sciences ... - The Voice Registrar (NASDAQ:BDSI)
voiceregistrar.com - September 28 at 3:51 PM
News IconUpgrades And Downgrades For BioDelivery Sciences International ... - NewsDen (NASDAQ:BDSI)
newsden.net - September 28 at 3:51 PM
News IconUnder the Microscope: Zeroing in on Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 26 at 3:57 PM
investornewswire.com logoBioDelivery Sciences International, Inc. (NASDAQ:BDSI) To Hit Price Target Of $13? - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - September 26 at 3:57 PM
News IconSell-side is Weighing in on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Earnings & Targets - Frisco Fastball (NASDAQ:BDSI)
friscofastball.com - September 25 at 3:33 PM
smarteranalyst.com logoBioDelivery Sciences International, Inc. (BDSI) Shares Open Higher on Back of Top Analyst Upgrade - Smarter Analyst (NASDAQ:BDSI)
www.smarteranalyst.com - September 24 at 3:42 PM
streetinsider.com logoJanney Montgomery Scott Upgrades BioDelivery Sciences International (BDSI) to Buy (NASDAQ:BDSI)
www.streetinsider.com - September 23 at 4:11 PM
thestreet.com logoBioDelivery Sciences (BDSI) Stock Jumps on Ratings Upgrade (NASDAQ:BDSI)
www.thestreet.com - September 23 at 4:11 PM
News IconUnder the Microscope, Zeroing in at BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 22 at 3:55 PM
News IconPenny Stock Investors Keen on Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 21 at 4:41 PM
prnewswire.com logoBioDelivery Sciences to Present at the Ladenburg Thalmann 2016 ... - PR Newswire (press release) (NASDAQ:BDSI)
www.prnewswire.com - September 21 at 4:41 PM
finance.yahoo.com logoBioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:BDSI)
finance.yahoo.com - September 21 at 4:41 PM
News IconPenny Stock Investors Take an Interest in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 20 at 5:55 PM
finance.yahoo.com logoBioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL - Yahoo Finance (NASDAQ:BDSI)
finance.yahoo.com - September 20 at 5:55 PM
realistinvestor.com logoBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Mean Price ... - RealistInvestor.com (NASDAQ:BDSI)
www.realistinvestor.com - September 20 at 5:55 PM
finance.yahoo.com logoBioDelivery Bunavail Gets Better Managed Care Positioning (NASDAQ:BDSI)
finance.yahoo.com - September 20 at 5:55 PM
bizjournals.com logoRaleigh's BDSI expands opioid treatment drug access with new contracts (NASDAQ:BDSI)
www.bizjournals.com - September 20 at 9:44 AM
biz.yahoo.com logoBIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:BDSI)
biz.yahoo.com - September 20 at 9:44 AM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Given ... - DailyQuint (NASDAQ:BDSI)
dailyquint.com - September 19 at 8:34 AM
prnewswire.com logoBioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to - PR Newswire (press release) (NASDAQ:BDSI)
www.prnewswire.com - September 19 at 8:34 AM
finance.yahoo.com logo7:03 am BioDelivery Sciences announces three new managed care contracts for BUNAVAIL (NASDAQ:BDSI)
finance.yahoo.com - September 19 at 8:34 AM
publicnow.com logoBioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL (NASDAQ:BDSI)
www.publicnow.com - September 19 at 8:34 AM
News IconKeen Investors Seek Information on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 17 at 8:37 AM
News IconWhat are Brokerage Firms Saying About BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? - Frisco Fastball (NASDAQ:BDSI)
friscofastball.com - September 16 at 8:19 AM
News IconStock Update, a Closer Look at BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 15 at 12:43 PM
News IconKeen Investors Narrowing Their Focus on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 14 at 9:01 PM
News IconShares in Focus: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Earnings & Targets Update - Frisco Fastball (NASDAQ:BDSI)
friscofastball.com - September 14 at 9:01 PM
News IconConsensus Estimates on Earnings & Stock Price in Focus for BioDelivery Sciences International, Inc. (NASDAQ:BDSI ... - Frisco Fastball (NASDAQ:BDSI)
friscofastball.com - September 14 at 6:17 AM
News IconGetting a Closer Look at Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 12 at 3:43 PM
News IconWhat is the Sell-side Saying About BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? - Frisco Fastball (NASDAQ:BDSI)
friscofastball.com - September 12 at 3:43 PM
investornewswire.com logoBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Median Stock Price Target At $7 - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - September 12 at 3:43 PM
News IconMaking News: Targeting shares of BioDelivery Sciences ... - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 9 at 3:44 PM
News IconFocusing the Spotlight on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 8 at 3:42 PM
News IconNarrowing the Lens on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 8 at 8:38 AM
News IconOTC Investors Supremely Interested in Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - September 6 at 8:54 PM
finance.yahoo.com logoBioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and … (NASDAQ:BDSI)
finance.yahoo.com - September 6 at 3:52 PM
capitalcube.com logoETF’s with exposure to BioDelivery Sciences International, Inc. : September 6, 2016 (NASDAQ:BDSI)
www.capitalcube.com - September 6 at 3:52 PM
News IconHot Biotech Stocks Recap: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Aratana Therapeutics, Inc ... - The Voice Registrar (NASDAQ:BDSI)
voiceregistrar.com - September 6 at 8:36 AM
finance.yahoo.com logoBioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and the 7th Annual Credit Suisse Small and Mid Cap Conference (NASDAQ:BDSI)
finance.yahoo.com - September 6 at 8:36 AM
News IconTaking a Serious Look at BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - August 31 at 3:46 PM
News IconTop Earnings to Watch for: BioDelivery Sciences International, Inc ... - The Voice Registrar (NASDAQ:BDSI)
voiceregistrar.com - August 31 at 8:34 AM
News IconZeroing Our Focus on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - August 30 at 3:45 PM
News IconPenny Stock Under the Microscope: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - August 25 at 9:13 PM
investornewswire.com logoBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - August 25 at 3:51 PM
News IconLooking Closer at Stocks of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - August 24 at 12:00 PM
News IconMagnifying Stocks of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Duncan Research (NASDAQ:BDSI)
www.duncanindependent.com - August 23 at 3:49 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Company In Focus: Analysts & Crowd Weigh in - Post News (NASDAQ:BDSI)
www.kentuckypostnews.com - August 23 at 5:38 AM
investornewswire.com logoWill BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Surprise Analysts? - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - August 22 at 3:50 PM
investornewswire.com logoWill BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Hit $13 Price Target? - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - August 18 at 3:57 PM

Social

BioDelivery Sciences International (NASDAQ:BDSI) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff